Potential Clinical and Economic Impact of Switching Branded Medications to Generics.

about

Substitutes of Prescription Medicines - A Review of Concerns Relevant to Doctors and Patients.

P2860

Q42029035-B4670988-1501-494C-B4D6-71C1187BB069

P2860

Potential Clinical and Economic Impact of Switching Branded Medications to Generics.

Item

http://www.wikidata.org/entity/Q33637817

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Potential Clinical and Economic Impact of Switching Branded Medications to Generics.

@ast

Potential Clinical and Economic Impact of Switching Branded Medications to Generics.

@en

type

Item

label

Potential Clinical and Economic Impact of Switching Branded Medications to Generics.

@ast

Potential Clinical and Economic Impact of Switching Branded Medications to Generics.

@en

prefLabel

Potential Clinical and Economic Impact of Switching Branded Medications to Generics.

@ast

Potential Clinical and Economic Impact of Switching Branded Medications to Generics.

@en

P1476

Potential Clinical and Economic Impact of Switching Branded Medications to Generics.

@en

P2093

Denis J Keohane

http://www.w3.org/2001/XMLSchema#string

Larry Z Liu

http://www.w3.org/2001/XMLSchema#string

Robert J Straka

http://www.w3.org/2001/XMLSchema#string

P2860

A pharmaco-economic analysis of patients with schizophrenia switching to generic risperidone involving a possible compliance loss

Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration.

Consumers' views on generic medicines: a review of the literature.

International harmonization of bioequivalence studies and issues shared in common.

Effectiveness, safety and cost of drug substitution in hypertension

Generic and therapeutic substitutions in the UK: are they a good thing?

The effect of switching on compliance and persistence: the case of statin treatment.

Norwegian patients on generic antihypertensive drugs: a qualitative study of their own experiences.

Special challenges for drug adherence following generic substitution in Pakistani immigrants living in Norway.

The bioequivalence and therapeutic efficacy of generic versus brand-name psychoactive drugs.

P304

e278-e289

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1097/MJT.0000000000000282

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2017-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26099048

http://www.w3.org/2001/XMLSchema#string

P921

generic drug

pharmaceutical preparation

P932

5417581

http://www.w3.org/2001/XMLSchema#string

Potential Clinical and Economic Impact of Switching Branded Medications to Generics.

about

P2860

P2860

Potential Clinical and Economic Impact of Switching Branded Medications to Generics.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932